PortfoliosLab logoPortfoliosLab logo
TNGX vs. GEV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TNGX vs. GEV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tango Therapeutics, Inc. (TNGX) and GE Vernova Inc. (GEV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TNGX achieves a 142.33% return, which is significantly higher than GEV's 46.98% return.


TNGX

1D
-0.14%
1M
-5.46%
YTD
142.33%
6M
124.35%
1Y
562.65%
3Y*
88.81%
5Y*
14.42%
10Y*

GEV

1D
-1.06%
1M
-10.67%
YTD
46.98%
6M
59.58%
1Y
95.04%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TNGX vs. GEV - Yearly Performance Comparison


2026 (YTD)20252024
TNGX
Tango Therapeutics, Inc.
142.33%186.73%-59.87%
GEV
GE Vernova Inc.
46.98%99.02%150.80%

Correlation

The correlation between TNGX and GEV is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Mar 28, 2024

0.13

Fundamentals

Market Cap

TNGX:

$3.08B

GEV:

$260.95B

EPS

TNGX:

-$0.89

GEV:

$34.12

PS Ratio

TNGX:

45.32

GEV:

6.69

PB Ratio

TNGX:

7.87

GEV:

18.74

Total Revenue (TTM)

TNGX:

$56.99M

GEV:

$39.38B

Gross Profit (TTM)

TNGX:

$55.33M

GEV:

$7.85B

EBITDA (TTM)

TNGX:

-$111.92M

GEV:

$3.32B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TNGX vs. GEV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TNGX
TNGX Risk / Return Rank: 9898
Overall Rank
TNGX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
TNGX Sortino Ratio Rank: 9898
Sortino Ratio Rank
TNGX Omega Ratio Rank: 9696
Omega Ratio Rank
TNGX Calmar Ratio Rank: 9999
Calmar Ratio Rank
TNGX Martin Ratio Rank: 9999
Martin Ratio Rank

GEV
GEV Risk / Return Rank: 8787
Overall Rank
GEV Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
GEV Sortino Ratio Rank: 8585
Sortino Ratio Rank
GEV Omega Ratio Rank: 8383
Omega Ratio Rank
GEV Calmar Ratio Rank: 9292
Calmar Ratio Rank
GEV Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TNGX vs. GEV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tango Therapeutics, Inc. (TNGX) and GE Vernova Inc. (GEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TNGXGEVDifference

Sharpe ratio

Return per unit of total volatility

6.52

1.97

+4.55

Sortino ratio

Return per unit of downside risk

5.05

2.75

+2.30

Omega ratio

Gain probability vs. loss probability

1.63

1.34

+0.29

Calmar ratio

Return relative to maximum drawdown

19.41

5.46

+13.96

Martin ratio

Return relative to average drawdown

51.43

12.49

+38.94

TNGX vs. GEV - Sharpe Ratio Comparison

The current TNGX Sharpe Ratio is 6.52, which is higher than the GEV Sharpe Ratio of 1.97. The chart below compares the historical Sharpe Ratios of TNGX and GEV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TNGXGEVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

6.52

1.97

+4.55

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.15

2.85

-2.70

Drawdowns

TNGX vs. GEV - Drawdown Comparison

The maximum TNGX drawdown since its inception was -93.64%, which is greater than GEV's maximum drawdown of -38.29%. Use the drawdown chart below to compare losses from any high point for TNGX and GEV.


Loading charts...

Drawdown Indicators


TNGXGEVDifference

Max Drawdown

Largest peak-to-trough decline

-93.64%

-38.29%

-55.35%

Max Drawdown (1Y)

Largest decline over 1 year

-29.24%

-17.51%

-11.73%

Max Drawdown (3Y)

Largest decline over 3 years

-91.46%

Max Drawdown (5Y)

Largest decline over 5 years

-93.64%

Current Drawdown

Current decline from peak

-22.69%

-16.54%

-6.15%

Average Drawdown

Average peak-to-trough decline

-48.20%

-6.84%

-41.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.02%

7.64%

+3.38%

Volatility

TNGX vs. GEV - Volatility Comparison

Tango Therapeutics, Inc. (TNGX) has a higher volatility of 27.67% compared to GE Vernova Inc. (GEV) at 12.57%. This indicates that TNGX's price experiences larger fluctuations and is considered to be riskier than GEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TNGXGEVDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.67%

12.57%

+15.10%

Volatility (6M)

Calculated over the trailing 6-month period

64.54%

36.64%

+27.90%

Volatility (1Y)

Calculated over the trailing 1-year period

91.07%

48.57%

+42.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

99.00%

52.85%

+46.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.52%

52.85%

+40.67%

Dividends

TNGX vs. GEV - Dividend Comparison

TNGX has not paid dividends to shareholders, while GEV's dividend yield for the trailing twelve months is around 0.16%.


PositionTTM20252024
GEV
GE Vernova Inc.
0.16%0.11%0.08%
TNGX
Tango Therapeutics, Inc.
0.00%0.00%0.00%

Financials

TNGX vs. GEV - Financials Comparison

This section allows you to compare key financial metrics between Tango Therapeutics, Inc. and GE Vernova Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B202220232024202520260
9.34B
(TNGX) Total Revenue
(GEV) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TNGX and GEV have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNGX has higher volatility (27.67%) compared to GEV (12.57%). In terms of maximum drawdown, TNGX dropped -93.64% vs GEV's -38.29%.

TNGX currently has the higher Sharpe Ratio (6.52 vs 1.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TNGX and GEV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer